Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal DHEA for Vaginal Dryness in Breast Cancer Survivors
NCT01724242Phase 3Withdrawn
- Sponsor
- Hadassah Medical Organization
- Start
- Feb 2013
- Primary completion
- Jan 2014
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in vaginal dryness, sponsored by Hadassah Medical Organization. Planned start Feb 2013; status: withdrawn.
02
Drugs
dehydroepiandrosterone
03
Conditions
vaginal dryness
Beyond the preview
Go deeper on NCT01724242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724242.